Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rxo (RXO) Tax Provisions (2021 - 2025)

Historic Tax Provisions for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to -$5.0 million.

  • Rxo's Tax Provisions rose 3750.0% to -$5.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$15.0 million, marking a year-over-year decrease of 714.29%. This contributed to the annual value of -$15.0 million for FY2025, which is 714.29% down from last year.
  • According to the latest figures from Q4 2025, Rxo's Tax Provisions is -$5.0 million, which was up 3750.0% from -$1.0 million recorded in Q3 2025.
  • Over the past 5 years, Rxo's Tax Provisions peaked at $15.0 million during Q2 2022, and registered a low of -$8.0 million during Q4 2024.
  • In the last 5 years, Rxo's Tax Provisions had a median value of -$1.0 million in 2024 and averaged $888888.9.
  • As far as peak fluctuations go, Rxo's Tax Provisions soared by 20000.0% in 2023, and later tumbled by 50000.0% in 2024.
  • Over the past 5 years, Rxo's Tax Provisions (Quarter) stood at $13.0 million in 2021, then tumbled by 115.38% to -$2.0 million in 2022, then surged by 200.0% to $2.0 million in 2023, then crashed by 500.0% to -$8.0 million in 2024, then surged by 37.5% to -$5.0 million in 2025.
  • Its Tax Provisions stands at -$5.0 million for Q4 2025, versus -$1.0 million for Q3 2025 and -$1.0 million for Q2 2025.